Connection
Mark Gregory to Treatment Outcome
This is a "connection" page, showing publications Mark Gregory has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.011 |
|
|
|
-
Gardner LA, Klawitter J, Gregory MA, Zaberezhnyy V, Baturin D, Pollyea DA, Takebe N, Christians U, Gore L, DeGregori J, Porter CC. Inhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1(+) leukemia. Am J Hematol. 2014 Sep; 89(9):896-903.
Score: 0.011